Area of research
Immunology and Allergy · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Idiopathic pulmonary fibrosis, Integrin, Cancer research, Disease, and Internal medicine.
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement
A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
Randomized Phase IIa Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
BAL Cell Gene Expression Is Indicative of Outcome and Airway Basal Cell Involvement in Idiopathic Pulmonary Fibrosis
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
Inhibition of αvβ5 Integrin Attenuates Vascular Permeability and Protects against Renal Ischemia-Reperfusion Injury
αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor
Integrin αvβ6 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis
Inhibition of the α<sub>v</sub>β<sub>6</sub> integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis
Therapy for Fibrotic Diseases: Nearing the Starting Line
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report